Microencapsulated nitrification inhibitor compositions

1. A stable microcapsule suspension formulation including:

(a) a first suspended phase of a plurality of microcapsules having a volume median particle size of from about 1 to about 10 microns, wherein the microcapsules include:

(1) a microcapsule wall produced by an interfacial polycondensation reaction between a polymeric isocyanate and a polyamine to form a polyurea shell; and

(2) at least one organic nitrification inhibiting compound selected from the group consisting of (trichloromethyl)pyridine compounds encapsulated within the polyurea shell;

(b) a second suspended phase of a plurality of microcapsules having a volume median particle size of from about 1 to about 10 microns, wherein the microcapsules include:

(1) a microcapsule wall produced by an interfacial polycondensation reaction between a polymeric isocyanate and a polyamine to form a second polyurea shell; and

(2) at least one hydrophobic crystal inhibitor additive encapsulated within the second polyurea shell; and

(c) an aqueous phase;

wherein the aqueous phase includes from 0 to 2.4% by wt. of non-microencapsulated hydrophobic crystal inhibitor, and less than 0.1% by wt. of crystals when stored at 40° C. for 4 weeks.

2. The microcapsule suspension formulation according to claim 1 , wherein the aqueous phase further includes an additional ingredient selected from the group consisting of: dispersants, emulsifiers, rheology aids, antifoam agents, biocides, antifreeze agents and mixtures thereof.

3. The microcapsule suspension formulation according to claim 2 , wherein the organic nitrification inhibiting compound includes 2-chloro-6-(trichloromethyl)pyridine.

4. The microcapsule suspension formulation according to claim 3 , wherein the formulation includes between about 15 weight percent and about 40 weight percent of the 2-chloro-6-(trichloromethyl)pyridine.

5. The microcapsule suspension formulation according to claim 2 , wherein the aqueous phase includes between about 1.0 weight percent and about 10 weight percent of the emulsifier.

6. The microcapsule suspension formulation according to claim 5 , wherein the emulsifier is a nonionic polymer surfactant selected from the group consisting of: polyvinyl alcohols.

7. The microcapsule suspension formulation according to claim 2 , wherein the dispersant is a modified styrene acrylic polymeric surfactant.

8. The microcapsule suspension formulation according to claim 1 , wherein the formulation further includes an agricultural active ingredient selected from the group consisting of: arthropodicides, bactericides, fungicides, herbicides, insecticides, miticides, nematicides, fertilizers, dicyandiamide, urease inhibitors, and pesticidal mixtures thereof.

9. The microcapsule suspension formulation according to claim 1 , further including at least one polymeric ultra-hydrophobe compound.

10. The microcapsule suspension formulation according to claim 9 , wherein the polymeric ultra-hydrophobe compound includes polybutene.

11. The microcapsule suspension formulation according to claim 1 , wherein the formulation includes between about 1.0 weight percent and about 10.0 weight percent of the microencapsulated hydrophobic crystal inhibitor additive.

12. The microcapsule suspension formulation according to either of claim 1 , wherein the hydrophobic crystal inhibitor additive is a compound selected from the group consisting of aromatic solvents and 2,2,4-trimethyl-1,3-pentanediol monoisobutyrate.

13. The microcapsule suspension formulation according to claim 12 , wherein the aromatic solvents include light aromatics, naphthalene depleted light aromatics, heavy aromatics, and/or naphthalene depleted heavy aromatics.

14. The microcapsule suspension formulation according to claim 1 , wherein the formulation includes between about 40 weight percent and about 70 weight percent of the aqueous phase.